My Portfolio
+
LINK YOUR PORTFOLIO

Danaher Corp DHR:NYSE

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:37 PM EDT
178.00quote price arrow down-0.08 (-0.04%)
Volume
140,730
Close
178.08quote price arrow up+1.97 (+1.12%)
Volume
2,766,645
52 week range
160.93 - 242.80
Loading...
  • Open175.86
  • Day High178.54
  • Day Low173.63
  • Prev Close176.11
  • 52 Week High242.80
  • 52 Week High Date01/22/26
  • 52 Week Low160.93
  • 52 Week Low Date05/15/26

Latest On Danaher Corp

Key Stats

  • Market Cap126.04B
  • Shares Out707.77M
  • 10 Day Average Volume4.30M
  • Dividend1.60
  • Dividend Yield0.90%
  • Beta0.81

KEY STATS

  • Open175.86
  • Day High178.54
  • Day Low173.63
  • Prev Close176.11
  • 52 Week High242.80
  • 52 Week High Date01/22/26
  • 52 Week Low160.93
  • 52 Week Low Date05/15/26
  • Market Cap126.04B
  • Shares Out707.77M
  • 10 Day Average Volume4.30M
  • Dividend1.60
  • Dividend Yield0.90%
  • Beta0.81

RATIOS/PROFITABILITY

  • EPS (TTM)5.15
  • P/E (TTM)34.57
  • Fwd P/E (NTM)20.84
  • EBITDA (TTM)7.79B
  • ROE (TTM)7.08%
  • Revenue (TTM)24.778B
  • Gross Margin (TTM)58.99%
  • Net Margin (TTM)14.83%
  • Debt To Equity (MRQ)34.91%

EVENTS

  • Earnings Date07/20/2026(est)
  • Ex Div Date06/26/2026
  • Div Amount0.40
  • Split Date-
  • Split Factor-

Related Video

VIDEO4:2704:27
Some of the market's top medtech names are trading at discounts, says Jim Cramer

Profile

MORE
Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment...
Steven Rales
Chairman of the Board
Rainer Blair
President, Chief Executive Officer, Director
Matthew Gugino
Group Chief Financial Officer
Christopher Riley
Executive Vice President
Greg Milosevich
Executive Vice President
Address
2200 Pennsylvania Ave NW Ste 800W
Washington, DC
20037-1701
United States